» Articles » PMID: 16468537

Long-term Results of Adrenalectomy in Patients with Aldosterone-producing Adenomas: Multivariate Analysis of Factors Affecting Unresolved Hypertension and Review of the Literature

Overview
Journal Am Surg
Specialty General Surgery
Date 2006 Feb 14
PMID 16468537
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The long-term surgical cure rate of patients with primary aldosteronism varies widely, and causes of persistent hypertension are not completely established. We reviewed retrospectively charts from 98 patients (range, 19-70 years old) with aldosterone-producing adenomas who underwent unilateral adrenalectomy. At a median follow-up of 81 months (range, 18-186 months), the mean blood pressure values improved in 95 out of 98 (96.9%) patients, although hypertension was cured only in 71 out of 98 (72.4%) patients. Multivariate analysis using a logistic regression model adjusted for duration of follow-up showed that only age of the patients and duration of the disease independently correlated with unresolved hypertension. The cumulative odds ratio (OR), obtained using the logistic regression function, was 5.38 (95% CI 1.78-16.22), and the OR of single variables were 1.32 (95% CI 0.36-19.83) and 4.56 (95% CI 1.41-14.78), respectively. By using discriminant analysis to derive a classification function for the prediction of unresolved hypertension, a maximum predictive power of 75 per cent was achieved. In conclusion, in patients with an aldosterone-producing adenoma undergoing surgery, the combination of age and duration of hypertension gave the best predictive power of a linear classification function and represented the main independent risk factors affecting hypertension cure rate.

Citing Articles

Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register.

Parra Ramirez P, Martin Rojas-Marcos P, Paja Fano M, Gonzalez Boillos M, Peris B, Pascual-Corrales E Endocrine. 2023; 84(2):683-693.

PMID: 38008883 DOI: 10.1007/s12020-023-03609-y.


'I can't understand why others don't screen more': a qualitative study exploring why Australian general practitioners screen for primary aldosteronism.

Nainani A, Yang J, Peters S, Russell G BMJ Open. 2022; 12(6):e061671.

PMID: 35697463 PMC: 9196168. DOI: 10.1136/bmjopen-2022-061671.


Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism.

Kim J, Ahn C, Kim S, Lee K, Kim J, Yoon H Endocrinol Metab (Seoul). 2022; 37(2):369-382.

PMID: 35417953 PMC: 9081309. DOI: 10.3803/EnM.2022.1391.


Surgical Outcomes Among Primary Aldosteronism Patients Without Visible Adrenal Lesions.

Sam D, Kline G, So B, Pasieka J, Harvey A, Chin A J Clin Endocrinol Metab. 2020; 106(2):e824-e835.

PMID: 33180934 PMC: 7823310. DOI: 10.1210/clinem/dgaa821.


Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Holler F, Heinrich D, Adolf C, Lechner B, Bidlingmaier M, Eisenhofer G Curr Hypertens Rep. 2019; 21(10):77.

PMID: 31482378 DOI: 10.1007/s11906-019-0985-0.